Susquehanna Fundamental Investments, LLC Galmed Pharmaceuticals Ltd. Transaction History

Susquehanna Fundamental Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.41 - $3.33 $24,582 - $33,966	-10,200 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$2.24 - $3.9 $3,808 - $6,630	-1,700 Reduced 14.29%	10,200 $31,000
Q1 2021 May 17, 2021	BUY	$3.19 - $5.4 $37,961 - $64,260	11,900 New	11,900 $41,000

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $76.5M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.